Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching

Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching

Objective: Thymosin alpha 1 (Thymosin-α1) is a potential treatment for patients with COVID-19. We aimed to determine the effect of Thymosin-α1 in non-severe patients with COVID-19.Methods: We retrospectively enrolled 1,388 non-severe patients with COVID-19. The primary and secondary clinical outcome...

Full description

Bibliographic Details
Main Authors: ChenLu Huang, Ling Fei, Wei Xu, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Medicine
Subjects:
severe acute respiratory syndrome coronavirus 2
coronavirus disease 2019
Thymosin alpha 1
Thymosin-α1
efficacy evaluation
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.664776/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.664776/full

Similar Items